U.S. Food and Drug Administration Center for Drug Evaluation and Research
Search
Click here to start presentation
Direct-to-Consumer Advertising of Prescription Drugs: Physician Survey Preliminary Results
FDA Physician Survey
2002 Physician Survey: Methodology
Patient-Initiated Questions about Treatments
How frequently do patients initiate questions about...
Frequency of Questions Over Last Five Years
Impact of DTC Advertising on Patient Interaction
Now think about the most recent interaction you’ve had with a patient who initiated a discussion about a prescription drug and told you he or she saw it advertised.
How representative was this patient encounter?
Beneficial Effects
What beneficial effects did it have?
Problems
What problems did it cause?
Patient Rx Inquiries, Requests, and Perceived Pressure to Prescribe
Brand Rx Inquiries and Patient Condition
Rx Requests and Prescribing Behavior
Brand Rx Requests and Prescribing Behavior
Reasons for not prescribing
Patient Influence on Interaction
Perceived Patient Influence
Perceived Pressure to Prescribe
Rx Requests and Perceived Pressure to Prescribe
Rx Requests and Perceived Pressure to Prescribe, con’t.
Brand Rx Requests and Perceived Pressure to Prescribe
Brand Rx Requests and Perceived Pressure to Prescribe, con’t.
Branded Rx Requests and Perceived Pressure to Prescribe
Unbranded Rx Requests and Perceived Pressure to Prescribe
Attitudes About Impact of DTCA on Patient Interaction
Because this patient saw the advertisement...
Attitudes About Impact of DTCA on Patient Understanding
What patients understand about advertised drugs...
Attitudes About Potential Negative Effects of DTCA on Patients and Practice
Problems DTCA Creates for My Patients and Practice...
Attitudes About Potential Positive Effects of DTCA on Patients and Practice
Benefits DTCA Creates for My Patients and Practice...
Overall Impact of DTCA on Patients and Practice
Division of Drug Marketing, Advertising, and Communications
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Download presentation source
Back to Top Back to DDMAC
FDA/Center for Drug Evaluation and Research Last Updated: January 13, 2003 Originator: OTCOM/DLIS HTML by SJW